glp-1 agonist dopamine Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives An endogenous GLP-1 circuit engages

Description

3337 In individuals with HFrEF, GLP-1 RAs do not affect LV systolic function, whereas the effects of GLP-1 RAs in individuals with HFpEF have not yet been investigated

Retrieved from Gibbons, C., Blundell, J., Tetens Hoff, S., et al

The innovations in drug design and formulation that we just covered, including dual and triple agonists or conjugates with other hormonal pathways, are helping driving this expansion by delivering greater weight loss and metabolic benefits while reducing side effects through synergistic mechanisms

GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway

Legal and Safety Considerations for Prescription GLP-1 Therapy Obtaining GLP-1 medications from any source without a valid prescription violates federal law and poses serious health risks